Publications by authors named "David Reparaz"

Claim this Profile
A
Average Dose Rate is the Major Temporal Beam Structure Parameter for Preserving Murine Intestines With Pulsed Electron FLASH Radiation Therapy.
Veljko Grilj, Anet Valdes Zayas, Anouk Sesink, Preethi Devanand, David Repáraz

Int J Radiat Oncol Biol Phys· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human T cells engineered with an HLA-A2-restricted murine T-cell receptor targeting glypican 3 effectively control human hepatocellular carcinoma in mice.
Enric Vercher, Ángela Covo-Vergara, Enrique Conde, Mercedes Hernández-Rueda, Edurne Elizalde

Hepatology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response.
Yaiza Senent, Ana Remírez, David Repáraz, Diana Llopiz, Daiana P Celias

Cancer Immunol Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for overcoming tumour resistance to immunotherapy: harnessing the power of radiation therapy.
Katiuska Passelli, David Repáraz, Remy Kinj, Fernanda G Herrera

Br J Radiol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of a murine hepatocellular carcinoma model by hydrodynamic injection and characterization of the immune tumor microenvironment.
David Repáraz, Noelia Casares, Andrea Fuentes, Flor Navarro

Methods Cell Biol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities and challenges of low-dose radiation to enable immunotherapy efficacy.
Katiuska Passelli, David Repáraz, Fernanda G Herrera

Int Rev Cell Mol Biol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer.
Belén Aparicio, David Repáraz, Marta Ruiz, Diana Llopiz, Leyre Silva

Front Immunol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination.
David Repáraz, Marta Ruiz, Leyre Silva, Belén Aparicio, Josune Egea

Front Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of dendritic cells in the immune niche of the peritoneum.
David Repáraz, Mirja Hommel, Flor Navarro, Diana Llopiz

Int Rev Cell Mol Biol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy.
Flor Navarro, Noelia Casares, Celia Martín-Otal, Aritz Lasarte-Cía, Marta Gorraiz, David Reparaz

Oncoimmunology· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoantigens as potential vaccines in hepatocellular carcinoma.
David Repáraz, Marta Ruiz, Diana Llopiz, Leyre Silva, Enric Vercher

J Immunother Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?
David Repáraz, Belén Aparicio, Diana Llopiz, Sandra Hervás-Stubbs, Pablo Sarobe

Int J Mol Sci· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy.
Diana Llopiz, Marta Ruiz, Leyre Silva, David Repáraz, Belén Aparicio

Cancer Lett· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses Against Hepatocellular Carcinoma.
Leyre Silva, Josune Egea, Lorea Villanueva, Marta Ruiz, Diana Llopiz

Cancers (Basel)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When Cancer Vaccines Go Viral.
David Repáraz, Diana Llopiz, Pablo Sarobe

Clin Cancer Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis